OnKure News and Activities

Acquisition, funding and merger involving OnKure.

• Reneo Pharmaceuticals and OnKure have merged  (posted on October 4 2024)..

View the org chart displaying its 29 main executives

Most searched biographies at OnKure

• Nicholas Saccomano, Director, President and Chief Executive Officer
• Michael Carruthers, Director
• Valerie Jansen, Director

Create your alert
to follow the executive moves at OnKure.

OnKure has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by OnKure

• News Releases | OnKure Therapeutics
• OnKure Therapeutics Announces $54 Million Series C Financing - OnKure, Inc.
• OnKure Therapeutics - Press Releases

Social media about OnKure

• OnKure on Wikipedia, Google News & Yahoo Finance
• OnKure on LinkedIn, X (Twitter) & YouTube